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KNOWLEDGE SUMMARY 
 
 
 
 
 
 
Clinical Scenario  
Antimicrobials such as amikacin sulphate or gentamicin sulphate are often added to corticosteroid 
preparations when performing intra-articular injections in horses. This summary aims to determine whether 
the risk of iatrogenic synovial sepsis increases in the absence of these antimicrobials and to consider whether 
injecting them concurrently with intra-articular corticosteroids is necessary. 
 
 
The evidence 
Of the three studies examined, only two studies directly evaluated the prevalence of iatrogenic synovial sepsis 
following intra-articular injection. Two out of the three studies were retrospective analyses of medical records 
(Smith et al., 2018 and Steel et al., 2013) and one was a survey based study with retrospective analyses of 
medical records submitted by questionnaire respondents (Gillespie et al., 2016). The searches also revealed an 
abstract by Smith et al. (2013) which was later published as a full study (Smith et al., 2018) and for the purposes 
of avoiding data replication, only the full study has been included. 
The scientific literature surrounding this topic was sparse and of inconsistent quality. There were no 
randomised controlled trials evaluating the risk of iatrogenic synovial sepsis following corticosteroid 
administration. Most studies comprised retrospective analyses of medical records, which are considered mid-
level in the hierarchy of evidence-based medicine (Murad et al., 2016). The number of cases of iatrogenic 
synovial sepsis was very low in all included studies; therefore evaluating risk factors using multivariable models 
may have been biased by a low number of events per variable. All included studies were likely to have 
insufficient statistical power to identify a true difference in incidence between different treatments (Peduzzi 
et al., 1996). 
 
 
 
PICO question 
In horses, does treatment with intra-articular antimicrobials concurrently with intra-articular corticosteroids 
reduce the risk of iatrogenic synovial sepsis compared to intra-articular corticosteroids alone? 
Clinical bottom line 
From the current literature, there is no evidence showing that intra-articular injection of antibiotics in 
conjunction with corticosteroids reduces the risk of synovial sepsis. However, the intra-articular injection of 
polysulphated glycosaminoglycans (PSGAGs) in combination with corticosteroids was noted as a risk factor for 
developing iatrogenic synovial sepsis and therefore concurrent antibiotic injection when administering 
PSGAGs may be warranted. The reported frequency of infection following intra-articular injections was very 
low (0.02–0.08%).  An overall prevalence of iatrogenic synovial sepsis following all intra-articular injections 
based on data from all included studies was calculated as 0.02% (CI 0.02–0.03%). However, due to the paucity 
of literature on the topic, further studies are required in this field to determine more accurate clinical 
recommendations. 
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Summary of the evidence 
Where prevalence and 95% confidence intervals (CI) were not provided in the publication, the author 
performed calculations where published data permitted using Epitools epidemiological calculators (Ausvet Pty 
Ltd., 2019). (Italics denote author calculations). 
 
1. Steel, C.M., Pannirselvam, R.R., & Anderson, G.A. (2013) 
Population: 16,624 intra-articular injections performed in 1103 Thoroughbred 
racehorses. 
Sample size: 16,624 injections in 1103 horses. 
Intervention details:  Cases included 16,624 joints injected in 1103 horses over a 45 
month period from 31 March 2002 to 31 December 2005. 15,934 
of these injections included corticosteroids. 
 Control group included all horses given intra-articular medication 
(IAM) on the same day, day before or the day after septic cases 
(224 control horses with 13 infected joint cases – no specific data 
was provided on injections for each case).  
 Standardised aseptic preparation procedure was used. Hair was 
not clipped and was scrubbed with 4% chlorhexidine for a 
minimum of 2 minutes, then 70% alcohol wipes.  
 Injections included corticosteroid (triamcinolone, 
betamethasone, dexamethasone or methylprednisolone) with or 
without amikacin sulphate, plus other unspecified medications. 
Doses were not recorded. 
 Non-sterile dressing applied to all except stifle and shoulder 
joints, where no dressing was applied. 
Study design: Retrospective and prospective descriptive study, with nested 
matched case-control. 
Outcome studied: Diagnosis of septic arthritis within 1–19 days following intra-articular 
injection and identification of any risk factors for this complication. 
Septic arthritis was diagnosed if synovial fluid bacterial culture was 
positive or if synovial fluid analysis revealed elevated total leucocyte 
count (>5.0 x 109/L) with a predominance of neutrophils (>80%) and 
increased total protein (>25 g/L). 
Main findings: 
(relevant to PICO question): 
 Of 16,624 joints injected in 1103 horses, septic arthritis occurred 
in only 13 joints (13 horses). 
 The risk of septic arthritis following intra-articular injection was 
one case per 1279 injections or 7.8 per 10,000 joints (prevalence 
0.08% [CI 0.05–0.13%]). 
 Of the 13 septic cases, 12 horses were injected with a 
corticosteroid plus or minus sodium hyaluronate (individual case 
details unspecified) and one was injected with a homeopathic 
anti-inflammatory product. 
 Risk factors identified were veterinary surgeon and type of 
corticosteroid. 
 Betamethasone had a lower risk of septic arthritis than 
dexamethasone. 
 
 
Veterinary Evidence 
ISSN:2396-9776 
Vol 4, Issue 4 
DOI: 10.18849/VE.V4I4.194    
next review date: 26 Feb 2021 
p a g e  |  4 of 12 
 
 
 
 When data for each joint location was compared there was no 
significant difference in the number of cases. 
 None of the 824 joints injected with amikacin developed septic 
arthritis. Of the 15,800 joints not injected with amikacin, 13 
developed iatrogenic synovial sepsis. There was no statistically 
significant association between the absence of amikacin and 
development of synovial sepsis (Fisher’s exact test P > 0.99). 
Limitations:  The effect of the individual performing skin preparation was not 
studied because information was unavailable for seven of the 13 
septic cases and for 50% of the nonseptic cases.  
 Study did not clarify whether veterinary surgeon or assistant 
performed skin preparation. Due to certain veterinary surgeons 
having an apparently higher rate of septic cases than others, this 
would have been useful information in order to determine if 
there were differences in aseptic technique despite a 
standardised procedure being in place. 
 Nonsterile dressing applied to all except stifle and shoulder 
joints, where no dressing was applied. 
 Medication doses were not recorded so association between 
corticosteroid dose and septic cases could not be evaluated. 
 Statistical validity of results is limited by a large number of 
injections with relatively low number of septic cases for 
comparison (resulting in a low number of events per variable for 
analysis of risk factors). 
 
 
 
2. Gillespie, C.C., Adams, S.B., & Moore, G.E. (2016) 
Population: Equine veterinarians who were members of the American 
Association of Equine Practitioners (AAEP) in 2014. 
Sample size: 241 surveys were returned containing details of 319,760 intra-
articular injections. 
Intervention details:  A link to an online survey was distributed to all members of the 
AAEP via email a total of three times between 17 March and 9 
May 2014. 
 The survey consisted primarily of multiple choice questions 
about intra-articular injection site preparation methods, 
injection methods, types of medication used and aftercare.  
 Several open questions and written responses were also 
included. 
 Guidelines were provided for determining joint sepsis. Medical 
records for septic cases were requested and analysed.   
Study design: Retrospective survey based cross-sectional study. 
Outcome studied: Reported rate of joint sepsis following intra-articular injection. 
Guidelines for diagnosing sepsis included one or more of: increased 
lameness score attributed to the injected joint, periarticular swelling, 
joint effusion, cloudy or turbid synovial fluid, elevated total protein 
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of the synovial fluid and elevated nucleated cell count of synovial 
fluid. 
Main findings: 
(relevant to PICO question): 
Only 26.6% of respondents (64/241 surveys) provided data 
regarding joint sepsis. 67/319,760 injected joints became septic 
following injection; 2.10 septic joints per 10,000 intra-articular 
injections (prevalence 0.02% [CI 0.02–0.03%]). 
 
No significant reduction in joint sepsis was noted with the 
concurrent intra-articular injection of antimicrobials. 
 
Infection rates were significantly lower when: 
 Veterinary surgeons prepared their own injection sites 
 Veterinary surgeons had fewer than 20 years of practice 
experience. 
Infection rates were significantly higher when: 
 Hair was removed at the injection site. 
 
Some findings were significant on the univariable analysis but were 
not retained in the final multivariable model. These included:  
 Lower infection rates when the intra-articular injection site was 
prepared for longer than 7 minutes 
 Lower infection rates when surgeons wore sterile or non-sterile 
gloves when performing the injection 
 Higher infection rates when veterinary surgeons used the same 
needle to draw up medications and perform the injection. 
Limitations:  Horses with septic joints diagnosed by one veterinary surgeon 
but injected by another (i.e. second opinions) were not included 
in the study. This could have falsely lowered the apparent 
infection rate, as approximately 60% of respondents reported 
treating infections in horses that were injected by other 
veterinary surgeons. 
 Risk of misclassification bias – the method of diagnosing synovial 
sepsis was recommended in the study, though the true method 
of diagnosis may have varied between veterinary respondents. 
 Study was questionnaire based and thus open to non-response, 
response and recall bias. 
 Response rate was low with only 241 respondents, which 
equates to a response rate of around 2.5% (241 responses from 
around 9600 veterinarians receiving the survey), with only 26.6% 
of respondents (64/241) providing data on joint infections. 
 Statistical validity of results is limited by a large number of 
injections with relatively low number of septic cases for 
comparison (resulting in a low number of events per variable for 
analysis of risk factors). 
 Exact numbers of corticosteroid injections and how many of 
these were septic were not provided, limiting the reliability of 
interpretation of these results in direct relevance to the PICO 
question. 
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3. Smith, L., Wylie, C.E., Palmer, L. & Ramzan, P.H.L. (2018) 
Population: Case records for every horse that received intra-synovial 
medications performed by 10 ambulatory clinicians in one UK 
equine hospital between 1 January 2006 and 31 December 2011. 
Sample size: 9456 intra-synovial injections in 1732 horses over 4331 sessions. 
Intervention details:  1732 horses receiving therapeutic intra-synovial injections using 
standardised aseptic technique.  
 Records were cross-referenced against admissions of synovial 
sepsis cases to the hospital and against cytology submissions.  
 Post-medication sepsis was considered if the horse developed 
two or more of four signs of synovial sepsis within 8 weeks of 
medication (listed below) and failed to respond to conservative 
therapy. 
Study design: Retrospective analysis of medical records. 
Outcome studied: Prevalence of iatrogenic synovial sepsis following intra-synovial 
injections.  
Synovial sepsis was defined as any horse developing two or more of 
four signs, including lameness, joint distension, synovial white blood 
cell count >10 x 109/L, or synovial total protein >25 g/L within 8 
weeks of intra-synovial medication of the same joint. Cases that 
resolved with conservative therapy (short courses of non-steroidal 
anti-inflammatory drugs and antimicrobials) were not diagnosed as 
septic. 
Main findings: 
(relevant to PICO question): 
 Frequency of iatrogenic synovial sepsis was very low (0.04%, 
4/9456). 
 89.3% of injections (3869/4331) included corticosteroids; 93.4% 
included amikacin (4044/4331). Dosages were not recorded. 
 Four horses developed iatrogenic synovial sepsis – two following 
injection of PSGAGs, one following triamcinolone acetonide 
combined with amikacin sulphate and one following 
triamcinolone acetonide alone.  
 Administration of intra-synovial PSGAGs was associated with an 
increased risk of iatrogenic synovial sepsis, though the 95% 
confidence intervals cross 0, therefore this finding was not 
statistically significant. 
 Concurrent injection of amikacin sulphate with any other intra-
synovial medication was associated with a low risk of developing 
iatrogenic synovial sepsis (attributable risk -1.02%, [CI -2.21–
0.16]), though the confidence interval crosses 0, therefore this 
finding was not statistically significant. 
Limitations:  93.4% of injections (4044/4331) included a prophylactic 
antibiotic (amikacin sulphate) so true risk of sepsis without 
concurrent antimicrobial administration is difficult to quantify. 
 Dosages of medications were not recorded. 
 High proportion of racehorses within study population may limit 
external validity. 
 Case definition of synovial sepsis in relation to descriptive clinical 
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parameters (lameness, joint swelling) was open to interpretation 
and may vary between veterinary surgeons. 
 Data analysed in sessions rather than per individual injection; 
there were 9456 injections performed in total, though data is 
analysed over 4331 sessions. 
 Statistical validity of results is limited by a large number of 
injections with relatively low number of septic cases for 
comparison (resulting in a low number of events per variable for 
analysis of risk factors). 
 
 
Appraisal, application and reflection 
 
The current literature suggests that the frequency of infection following all intra-articular injections (including 
corticosteroids, antimicrobials, anaesthetic agents, PSGAGs, combinations of the above and any other 
unspecified or unlisted medication included in the studies reviewed) is very low and equates to roughly one case 
per 1000 or 2364 injections, according to Steel et al. (2013) and Smith et al. (2018) respectively. These figures 
equate to a prevalence of iatrogenic sepsis of 0.02–0.08%. The overall prevalence of synovial sepsis following all 
intra-articular injections based on data from all included studies was calculated as 0.02% [CI 0.02–0.03%]. The 
prevalence of synovial sepsis following corticosteroid injections across three studies which provided the 
necessary data (Smith et al., 2018 and Steel et al., 2013) was 0.07% [CI 0.04–0.012%].  
 
Table 1: Prevalence estimates for synovial sepsis for all intra-articular injections across all studies (as calculated 
by author of this Knowledge Summary). 
 
Study Injections  Septic cases Prevalence (%) CI (%) 
Steel et al. 
(2013) 16,624 13 0.08 0.05–0.13 
Gillespie et 
al. (2016) 319,760 67 0.02 0.02–-0.03 
Smith et al. 
(2018) 9456 4 0.04 0.02–-0.11 
ALL 345,840 84 0.02 0.02–0.03 
 
Table 2: Prevalence estimates for iatrogenic synovial sepsis following corticosteroid injections in the only two 
included studies which provided the necessary data (as calculated by the author of this Knowledge Summary). 
 
Study 
Corticosteroid 
Injections Septic cases Prevalence (%) CI (%) 
Steel et al. 
(2013) 15,934 12 0.08 0.04–0.13 
Smith et al. 
(2018) 3,871 2 0.05 0.01–0.19 
ALL 19,805 14 0.07 0.04–0.12 
 
From the studies examined, there is no evidence that injecting antibiotics in conjunction with corticosteroids 
reduces the frequency of synovial sepsis following intra-articular injection. 
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There is some evidence indicating that the risk of iatrogenic synovial sepsis following intra-articular medication 
may be increased by a number of factors, including: 
 The veterinary surgeon not performing the skin preparation herself/himself 
 The veterinary surgeon being qualified for over 20 years 
 Clipping the injection site 
 Skin preparation with chlorhexidine for fewer than 7 minutes* 
 Not wearing gloves* 
 Using the same needle to draw up medications and to inject the joint* 
 
(* denotes factors that were statistically significant on univariable analysis though not on multivariable 
analysis (Gillespie et al., 2016)) 
 
One of the included studies provided weak evidence of an increased risk of synovial sepsis following the injection 
of PSGAGs. Smith et al. (2018) reported that injection of PSGAGs was positively associated with iatrogenic 
synovial sepsis, though this finding was not statistically significant. In an abstract found in the literature search 
(though not included in the Knowledge Summary as it was an unpublished proceedings expanded abstract), 
Bohlin et al. (2014) also reported that injection of PSGAGs in combination with corticosteroids appeared to 
increase the risk of infection. Although not included in the summarised evidence due to it not meeting the 
inclusion criteria, a paper by Gustafson et al. (1989) reported that PSGAGs potentiate the risk of iatrogenic 
infection. Gustafson found that intra-articular injection of 125 mg amikacin immediately after inoculating the 
joint with Staphylococcus aureus significantly decreased the potentiation of infection by the PSGAG. From this 
data, it can be concluded that concurrent injection with antimicrobials when injecting PSGAGs may be 
warranted. Further studies with larger sample sizes would be required to confirm whether concurrent antibiotic 
administration when injecting PSGAGs is necessary. 
 
Responsible use of antimicrobials is of paramount importance across all health sectors, and making appropriate, 
evidence-based choices is crucial to preventing the development of antimicrobial resistance. Therefore, the 
following recommendations can be made: 
 
 Sterile skin preparation should be performed for a minimum of 7 minutes when using chlorhexidine, 
ideally by the veterinary surgeon performing the intra-articular injection. 
 Gloves should be worn for skin preparation as well as for intra-articular injection. 
 Needles should be changed after drawing up medications and before intra-articular injection.  
 Veterinary surgeons should consider not clipping the injection site, though this will depend on the length 
of hair, visibility of landmarks and gross contamination of the surrounding hair and skin.  
 Intra-articular injection of antimicrobials is unlikely to be necessary, though may be warranted if PSGAGs 
are being injected. 
 
Although some of the above factors were only statistically significant on univariable analysis rather than on 
multivariable analysis, they have been included in the clinical recommendations for performing intra-articular 
injections as they are factors that may be implemented with ease in a clinical setting. A systematic review of 
aseptic skin preparation procedures for intra-articular injections in horses would be of benefit to equine 
practitioners, with particular attention on clipping and the substance used for disinfection (e.g. chlorhexidine or 
iodine). An investigation of skin preparation protocols in relation to septic arthritis rates would also be of great 
benefit to equine practitioners.  
 
The quality of the evidence included in this summary is mixed. Only three studies were found and one of those 
three did not provide enough information regarding exact medications injected (corticosteroids vs others) to 
accurately interpret the results with direct relevance to the PICO question (Gillespie et al., 2016). None of the 
studies rank highly in the hierarchy of research and evidence-based medicine (Arlt & Heuwieser, 2016 and 
Murad et al., 2016). The poor quality and heterogeneity of the studies precluded meta-analysis of their results.  
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In answer to the PICO question, it can be concluded that injecting antibiotics in conjunction with corticosteroids 
is likely to be unnecessary. However, there is a paucity of strong, evidence based research on the subject. 
Although the available studies provide useful data, they have limited external validity and insufficient statistical 
power. Further studies are required in this area to reach a definitive conclusion for this particular PICO question. 
Given the very low frequency of iatrogenic synovial sepsis following intra-articular injection reported in the 
included studies, a randomised controlled trial is unlikely to be feasible and a multicenter case control study 
would likely be required in order to recruit an adequate number of cases to achieve sufficient statistical power. 
 
 
 
 
Methodology Section 
 
 
Search Strategy 
Databases searched and dates 
covered: 
CAB Abstracts – 1973 to 26 February 2019.  
Pubmed via the NCBI website; 1910 to 26 February 2019 
Science Direct – Elsevier – unknown to 26 February 2019  
Scopus – unknown to 26 February 2019 
Wiley Online Library – unknown to 26 February 2019 
Search terms: The search terms used for CAB Abstracts, Pubmed, Wiley Online 
Library and Scopus were: 
Search 1: “(intra-articular OR intraarticular OR intra-synovial OR joint 
OR synovial OR articular) AND (injection OR medication OR 
administration ) AND (corticosteroid OR cortico-steroid OR steroid 
OR corticoid OR betamethasone OR triamcinolone OR 
methylprednisolone OR dexamethasone) AND (risk OR risks OR 
infection OR sepsis OR complication OR complications) AND 
(antibiotic OR antimicrobial OR antibacterial OR amikacin OR 
gentamicin OR antibiosis OR anti-microbial OR antibiotics OR 
antimicrobials) AND (horse OR horses OR equine)”.  
 
Search 2: “(intra-articular OR intraarticular OR joint OR synovial OR 
articular) AND (injection OR medication) AND (corticosteroid OR 
cortico-steroid OR steroid OR corticoid OR betamethasone OR 
triamcinolone OR methylprednisolone OR dexamethasone) AND (risk 
OR risks OR infection OR sepsis OR complication OR complications) 
AND (horse OR horses OR equine)”.  
 
Search 3: “(intra-articular OR intraarticular OR joint OR synovial OR 
articular) AND (injection OR medication) AND (antibiotic OR 
antimicrobial OR antibacterial OR amikacin OR gentamicin OR 
antibiotics OR anti-microbial) AND (horse OR horses OR equine)”. 
 
The search terms for Science Direct (which does not support 
searches of more than eight Boolean connectors per field), as well as 
all of the databases mentioned above were: 
Search 4: “(intra-articular OR intraarticular OR joint OR synovial OR 
articular) AND (injection OR medication) AND (infection OR sepsis) 
AND (horse OR horses OR equine)”.  
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Reference lists and bibliographies of discovered articles were also 
examined to identify other relevant publications, none of which 
were found. 
 
The Wiley Online Library search yielded 1344 results with Search 1, 
necessitating subject refinement to Veterinary Medicine, Medical 
Science and Equine Science. 
Dates searches performed: 26 February 2019 
 
 
 
Exclusion / Inclusion Criteria 
Exclusion: Studies not related to the PICO question 
Studies performed in other species 
Non-English language publications 
Abstract and full text unavailable 
Inclusion: Studies relevant to the PICO question in the English language 
 
 
Please add rows as necessary 
Search Outcome 
Database 
Number 
of 
results 
Excluded – 
not related 
to PICO 
Excluded – 
studies in other 
species 
Excluded – Non-
English language 
Excluded – 
abstract and 
full text 
unavailable 
Total 
relevant 
papers 
CAB 
Abstracts 
129 124 0 1 1 3 
Pubmed 115 112 0 0 1 2 
Science 
Direct 
275 2 272 1 0 0 
Scopus 51 46 1 0 1 3 
Wiley Online 
Library 
1,344 209 1,129 1 2 3 
Total relevant papers when duplicates removed 3 
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